Long-term effects of rituximab in the treatment of systemic lupus erythematosus.

被引：0
作者：
Anolik, JH [1 ]
Barnard, J [1 ]
Looney, RJ [1 ]
Sanz, I [1 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S190 / S191
页数：2
相关论文
共 50 条
  • [31] Long-term benefits of rituximab (anti-CD20) for refractory systemic lupus erythematosus
    Tanaka, Y.
    Tokunaga, M.
    Nawata, M.
    Suzuki, K.
    Iwata, S.
    Yamaoka, K.
    Nakayamada, S.
    Saito, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 483 - 483
  • [32] Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: long-term benefit of rituximab
    Martinez-Martinez, M. U.
    Abud-Mendoza, C.
    LUPUS, 2012, 21 (10) : 1124 - 1127
  • [33] ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS. EFFECTS OF STATINS TREATMENT
    Barbarroja, N.
    Ruiz-Limon, P.
    Perez-Sanchez, C.
    Aguirre, M. A.
    Khamastha, M. A.
    Rodriguez-Ariza, A.
    Gonzalez-Reyes, J. A.
    Kraiwesh, H.
    Villalba-Montoro, J. M.
    Collantes-Estevez, E.
    Cuadrado, M. J.
    Lopez-Pedrera, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 865 - 865
  • [34] Long-term remission in patients with systemic lupus erythematosus
    Nikfar, Mozhdeh
    Malek Mahdavi, Aida
    Khabbazi, Alireza
    Hajialilo, Mehrzad
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [35] Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus
    Yafasova, Adelina
    Fosbol, Emil L.
    Schou, Morten
    Baslund, Bo
    Faurschou, Mikkel
    Docherty, Kieran F.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Sun, Guoli
    Kristensen, Soren L.
    Torp-Pedersen, Christian
    Kober, Lars
    Butt, Jawad H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 77 (14) : 1717 - 1727
  • [36] CYCLOSPORINE A IN THE LONG-TERM MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Germano, V.
    Diamanti, A. Picchianti
    Ferlito, C.
    Podesta, E.
    Salemi, S.
    Migliore, A.
    D'Amelio, R.
    Lagana, B.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (03) : 397 - 403
  • [37] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus.
    Albert, D
    Khan, S
    Stansberry, J
    Kolasinski, S
    Tsai, D
    Kamoun, M
    Eisenberg, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S446 - S447
  • [38] An etiology for systemic lupus erythematosus.
    James, JA
    Kaufman, KM
    Farris, AD
    TaylorAlbert, E
    Lehman, TJA
    Harley, JB
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 803 - 803
  • [39] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus.
    Albert, DA
    Khan, SR
    Stansberry, J
    Tsai, D
    Eisenberg, RA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3659 - 3659
  • [40] Neuropsychiatric systemic lupus erythematosus.
    Harten, P
    AKTUELLE RHEUMATOLOGIE, 1996, 21 (02) : 77 - 88
12345